Belpointe Asset Management LLC Aspira Women'S Health Inc. Transaction History

Belpointe Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.3 - $0.41 $46,030 - $62,908	153,435 New	153,435 $50,000
Q3 2021 Nov 15, 2021	SELL	$3.19 - $5.48 $78,001 - $133,996	-24,452 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$4.78 - $6.84 $38,010 - $54,391	7,952 Added 48.19%	24,452 $137,000
Q1 2021 May 14, 2021	SELL	$5.9 - $9.13 $1,180 - $1,826	-200 Reduced 1.2%	16,500 $111,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.71 $50,100 - $112,057	16,700 New	16,700 $112,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.